PEF failed to consistently reflect FEV1 improvements after bronchodilation, indicating that handheld spirometry may better ...

NEW ORLEANS — Use of spirometry with bronchodilator testing can help reduce overdiagnosis of COPD as well as help differentiate COPD from asthma and asthma-COPD overlap syndrome, researchers ...

When it comes to treating teens and adults with persistent asthma, using a single corticosteroid and long-acting bronchodilator treatment for both daily asthma control and for rescue relief during ...

Novartis’ dual combination bronchodilator Utibron Neohaler inhalation powder for patients with chronic obstructive pulmonary disease (COPD) has received FDA approval. The FDA decision was based ...

HealthDay News — Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March 11 in Thorax. Ben Knox ...

Notably, the likelihood for bronchodilator responsiveness per the 2005 definition significantly went down with testing in autumn vs. winter (aOR = 0.67; 95% CI, 0.48-0.92), according to the study.

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease. J Thorac Dis. 2021;13 (2): 511-520. doi: 10.21037/jtd-20-985 ...

"Little Evidence Behind Bronchodilator Therapy For Cystic Fibrosis." ScienceDaily. ScienceDaily, 26 October 2005. <www.sciencedaily.com / releases / 2005 / 10 / 051026085739.htm>.

Each patient's bronchodilator responsiveness (BDR) was determined by three measures: absolute change in the volume of air exhaled during a forced breath in one second (FEV1) (BDRABS); change as ...

A significantly lower bronchodilator treatment rate was associated with COPD patients with comorbid CVD compared to those without CVD (32.3% vs. 57.6%, respectively); deprescribing occurred more ...

Cite this: Unpredictability of Deception in Compliance With Physician-Prescribed Bronchodilator Inhaler Use in a Clinical Trial - Medscape - Aug 01, 2000.